Another Milestone Crossed: Fluoroquinolones, The FDA, and Psychiatric Adverse Events
In an astonishing statement from the FDA, they acknowledged that since “Psychiatric Effects” will specifically be identified within the “Central Nervous System Effects” subheading, psychiatric adverse events are automatically assumed to be part of the existing Black Box warning.